Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves …
Over the last 12 months, insiders at Accolade, Inc. have bought $0 and sold $2.43M worth of Accolade, Inc. stock.
On average, over the past 5 years, insiders at Accolade, Inc. have bought $178,758 and sold $4.23M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 74 shares for transaction amount of $743 was made by Barnes Stephen H. (Chief Financial Officer) on 2022‑08‑02.
2024-11-04 | Sale | Chief Executive Officer | 1,545 0.0019% | $3.15 | $4,865 | +9.40% | ||
2024-11-04 | Sale | Chief Financial Officer | 458 0.0006% | $3.15 | $1,442 | +9.40% | ||
2024-11-04 | Sale | President | 475 0.0006% | $3.15 | $1,496 | +9.40% | ||
2024-11-04 | Sale | Chief Accounting Officer | 448 0.0005% | $3.15 | $1,411 | +9.40% | ||
2024-11-04 | Sale | EVP General Counsel | 336 0.0004% | $3.15 | $1,058 | +9.40% | ||
2024-10-17 | Sale | Chief Executive Officer | 385 0.0005% | $3.67 | $1,413 | -7.82% | ||
2024-10-17 | Sale | Chief Financial Officer | 122 0.0002% | $3.67 | $448 | -7.82% | ||
2024-10-17 | Sale | President | 157 0.0002% | $3.67 | $576 | -7.82% | ||
2024-10-11 | Sale | Chief Executive Officer | 680 0.0008% | $3.77 | $2,564 | -10.82% | ||
2024-10-11 | Sale | Chief Financial Officer | 228 0.0003% | $3.77 | $860 | -10.82% | ||
2024-10-11 | Sale | President | 217 0.0003% | $3.77 | $818 | -10.82% | ||
2024-10-02 | Sale | Chief Executive Officer | 1,540 0.0018% | $3.70 | $5,704 | -2.52% | ||
2024-10-02 | Sale | Chief Financial Officer | 456 0.0005% | $3.70 | $1,689 | -2.52% | ||
2024-10-02 | Sale | President | 474 0.0006% | $3.70 | $1,756 | -2.52% | ||
2024-10-02 | Sale | Chief Accounting Officer | 448 0.0005% | $3.70 | $1,659 | -2.52% | ||
2024-10-02 | Sale | EVP General Counsel | 334 0.0004% | $3.70 | $1,237 | -2.52% | ||
2024-09-17 | Sale | Chief Executive Officer | 366 0.0005% | $4.32 | $1,580 | -12.99% | ||
2024-09-17 | Sale | Chief Financial Officer | 117 0.0001% | $4.32 | $505 | -12.99% | ||
2024-09-17 | Sale | President | 149 0.0002% | $4.32 | $643 | -12.99% | ||
2024-09-11 | Sale | Chief Executive Officer | 672 0.0008% | $3.91 | $2,628 | +0.49% |
SINGH RAJEEV | Chief Executive Officer | 794574 0.9866% | $3.45 | 1 | 63 | +16.34% |
Barnes Stephen H. | Chief Financial Officer | 204452 0.2539% | $3.45 | 2 | 62 | +16.34% |
Brown Advisory | $61.27M | 7.42 | 5.85M | -1.96% | -$1.22M | 0.08 | |
BlackRock | $59.33M | 7.18 | 5.66M | +<0.01% | +$2,378.96 | <0.01 | |
ARK Investment Management LLC | $58.82M | 7.12 | 5.61M | -17.52% | -$12.49M | 0.2 | |
The Vanguard Group | $56.63M | 6.85 | 5.4M | +1.45% | +$807,421.12 | <0.01 | |
JPMorgan Chase | $55.87M | 6.76 | 5.33M | -16.83% | -$11.31M | 0.01 |